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ARTICLE
Bacillus cereus non-haemolytic enterotoxin activates
the NLRP3 inﬂammasome
Daniel Fox 1,10, Anukriti Mathur 1,10, Yansong Xue1, Yunqi Liu1, Wei Hong Tan1, Shouya Feng1,
Abhimanu Pandey1, Chinh Ngo1, Jenni A. Hayward1, Ines I. Atmosukarto2, Jason D. Price2, Matthew D. Johnson3,
Nadja Jessberger4, Avril A.B. Robertson 5, Gaetan Burgio 1, David C. Tscharke 1, Edward M. Fox6,
Denisse L. Leyton3,7, Nadeem O. Kaakoush8, Erwin Märtlbauer 4, Stephen H. Leppla9 & Si Ming Man 1*
Inﬂammasomes are important for host defence against pathogens and homeostasis with
commensal microbes. Here, we show non-haemolytic enterotoxin (NHE) from the neglected
human foodborne pathogen Bacillus cereus is an activator of the NLRP3 inﬂammasome and
pyroptosis. NHE is a non-redundant toxin to haemolysin BL (HBL) despite having a similar
mechanism of action. Via a putative transmembrane region, subunit C of NHE initiates
binding to the plasma membrane, leading to the recruitment of subunit B and subunit A, thus
forming a tripartite lytic pore that is permissive to efﬂux of potassium. NHE mediates killing of
cells from multiple lineages and hosts, highlighting a versatile functional repertoire in dif-
ferent host species. These data indicate that NHE and HBL operate synergistically to induce
inﬂammation and show that multiple virulence factors from the same pathogen with con-
served function and mechanism of action can be exploited for sensing by a single
inﬂammasome.
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B acillus cereus is a clinically important human foodbornepathogen. This Gram-positive and rod-shaped bacteriumis found ubiquitously in the environment and in under-
cooked and processed food products1. Ingestion of B. cereus
endospores often leads to germination and propagation of viable
vegetative cells in the human gastrointestinal tract, which may
lead to emetic and diarrheal syndromes largely depending on the
production of enterotoxins2. Of concern is the potential for
B. cereus to cause often-fatal extra-gastrointestinal disease in
immune-compromised patients, including systemic bacterial
septicemia, ocular infections, anthrax-like pneumonia, cutaneous
gas-gangrene-like infections, and infections of the central nervous
system1.
The critical components of host innate immune defence against
invading pathogens are cytosolic inﬂammasome complexes3–5.
Several inﬂammasome sensor proteins have been identiﬁed,
including AIM2, NAIP-NLRC4, NLRP1, NLRP3, NLRP6, NLRP9b,
Pyrin, and caspase-116,7. These inﬂammasome sensors, when
activated, can recruit the inﬂammasome adaptor protein apoptosis-
associated speck-like protein containing a caspase activation and
recruitment domain (ASC, also known as PYCARD), which further
recruits the cysteine protease caspase-18,9. Caspase-1 is required to
induce cleavage of the proinﬂammatory cytokines pro-interleukin-
1β (pro-IL-1β) and pro-IL-18, as well as the pro-pyroptotic factor,
gasdermin D (GSDMD)10–13, to drive an inﬂammatory form of
programmed cell death known as pyroptosis.
Inﬂammasome sensor proteins can recognize pathogen-
associated molecular patterns (PAMPs), danger-associated mole-
cular patterns, and the more recently proposed homeostasis-
altering molecular processes14,15.
Bacterial toxins are key virulence factors that represent a class of
PAMPs, which are potent activators of inﬂammasome sensors,
leading to inﬂammation and cell death in the host14,16. The lethal
factor from the anthrax-causing pathogen Bacillus anthracis can
enter the host cell cytoplasm and induce cleavage of the inﬂam-
masome sensor NLRP1b17–23. Unlike the lethal factor, the toxins
TcdA and TcdB produced by the gastrointestinal pathogen Clos-
tridium difﬁcile inactivate host Rho-GTPases in the cytoplasm.
This homeostasis-altering event induces dephosphorylation and
activation of the inﬂammasome sensor Pyrin, triggering assembly
of the Pyrin inﬂammasome24. We and others have shown that
more structurally diverse toxins can induce activation of the
NLRP3 inﬂammasome via a mechanism independent of entry to
the host cell cytoplasm. These toxins include haemolysins of
Staphylococcus aureus25–28 and Escherichia coli29,30, and haemo-
lysin BL (HBL) of B. cereus31.
Of particular interest is that B. cereus isolates that lack HBL can
cause inﬂammation and disease in humans32–34, suggesting that
other non-redundant virulence factors are critical in the patho-
genesis of this pathogen. Here, we identify that non-haemolytic
enterotoxin (NHE) of B. cereus is able to induce activation of the
NLRP3 inﬂammasome and pyroptosis via a mechanism targeting
the plasma membrane of host cells. We also demonstrate that
NHE subunits assemble to form a functional pore, driving efﬂux
of cytosolic potassium. This toxin kills cell types from multiple
lineages and host origin, highlighting its functional repertoire in
different host species. Our results reveal that multiple functionally
conserved toxins from B. cereus are targeted by a single inﬂam-
masome to initiate inﬂammation and cell death in the host. This
host strategy offers a single pathogen sensor the ﬂexibility to
mediate the recognition of functionally conserved toxins, often
produced by phylogenetically diverse bacterial species or even
within different strains of a single bacterial species.
Results
A non-redundant secreted factor of B. cereus activates NLRP3.
We have previously demonstrated that innate immune recogni-
tion of Bacillus cereus infection requires inﬂammasome-mediated
sensing of a toxin known as HBL31. Stimulation of primary wild-
type (WT) bone marrow-derived macrophages (BMDMs) with
the supernatant of WT B. cereus led to activation of caspase-1,
cleavage of GSDMD, secretion of IL-1β and IL-18, and pyroptosis
within 3 h, whereas stimulation of WT BMDMs with the super-
natant of an isogenic mutant of B. cereus lacking HBL (ΔHbl B.
cereus) did not (Fig. 1a–d), consistent with our previous ﬁnd-
ings31. However, we were surprised to ﬁnd that WT BMDMs
treated overnight with the supernatant of ΔHbl B. cereus
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Fig. 1 A secreted factor of B. cereus activates the inﬂammasome independently of HBL. a Immunoblot analysis of pro-caspase-1 (Casp-1), the active
caspase-1 p20 subunit, pro-pyroptotic effector protein gasdermin D (GSDMD), the active GSDMD p30 subunit of WT BMDMs left untreated [Medium
alone (Med.)] or LPS-primed and assessed either 3 h or 20 h after stimulation with the supernatant of WT B. cereus (B. cer.) or ΔHbl B. cereus (ΔHbl) (top;
Supernatant (Sup.)) or infection with B. cer. or ΔHbl (bottom; m.o.i. of 5). Release of IL-1β b, IL-18 c, and cell death d of BMDMs as treated in a. NS, not
signiﬁcant, ***P < 0.001 and ****P < 0.0001 (student’s unpaired t test b–d). Each symbol represents an independent experiment b–d. Data are
representative of three independent experiments (n= 3, a–d; mean and s.e.m. in b–d). Source data are provided as a Source Data ﬁle.
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underwent robust activation of caspase-1, cleavage of GSDMD,
secretion of IL-1β and IL-18, and induction of cell death
(Fig. 1a–d). We further conﬁrmed that live ΔHbl B. cereus bac-
teria also induced activation of the inﬂammasome in WT
BMDMs following overnight stimulation (Fig. 1a–d). These
ﬁndings suggest that an additional non-redundant secreted factor
of B. cereus might be sensed by the inﬂammasome.
To elucidate the identity of the inﬂammasome sensor
responsible for the recognition of the secreted factor, we
stimulated lipopolysaccharide (LPS)-primed primary WT,
Nlrp3–/–, Nlrc4–/–, Aim2–/–, Asc–/–, Casp1/11–/–, and Casp11–/–
BMDMs with the supernatant of ΔHbl B. cereus. The supernatant
of ΔHbl B. cereus induced caspase-1 activation, cleavage of
GSDMD, secretion of IL-1β and IL-18, and cell death in WT,
Nlrc4–/–, Aim2–/–, and Casp11–/– BMDMs (Fig. 2a–c). In contrast,
the supernatant of ΔHbl B. cereus did not induce activation of the
inﬂammasome and cell death in Nlrp3–/– and Asc–/– BMDMs
(Fig. 2a–c), indicating that NLRP3 is the cytosolic sensor of the
secreted factor of ΔHbl B. cereus. Consistent with the results
obtained using cell-free supernatant, we found that live ΔHbl
B. cereus bacteria activated the NLRP3 inﬂammasome (Fig. 2a, b
and Supplementary Fig. 1a).
Gene and protein expression analyses of proinﬂammatory
cytokines tumor-necrosis factor (TNF), keratinocyte chemoattrac-
tant (KC, also known as CXCL1) and pro-IL-1β, and the
phosphorylation status of IκB and ERK between WT and
Nlrp3–/– BMDMs following stimulation by the supernatant or
live bacteria of ΔHbl B. cereus were similar (Fig. 2b and
Supplementary Fig. 1b–d). These data conﬁrm that the production
of inﬂammasome-independent cytokines was not affected by the
genetic deletion of NLRP3, and that the unknown secreted factor
did not affect priming of the inﬂammasome.
We further conﬁrmed that assembly of the inﬂammasome
complex, which can be visualized by immunostaining of the ASC
speck35, occurred in WT BMDMs treated with the supernatant
from either WT B. cereus or ΔHbl B. cereus or infected with either
WT B. cereus or ΔHbl B. cereus (Fig. 2d and Supplementary
Fig. 1e). Further, pharmacological inhibition of NLRP3 using the
small molecule inhibitor MCC95036–38 abrogated caspase-1
activation, secretion of IL-1β and IL-18, and cell death in WT
BMDMs stimulated with the supernatant or live bacteria of ΔHbl
B. cereus (Supplementary Fig. 1f). Collectively, our data suggest
that a putative secreted factor of ΔHbl B. cereus activates the
NLRP3 inﬂammasome.
The secreted factor is a 30–50 kDa heat-sensitive protein. To
decipher the biological identity of the putative secreted
inﬂammasome-activating factor, we stimulated WT BMDMs
overnight with the supernatant of ΔHbl B. cereus, which had been
heat-treated or treated with proteinase K, DNase, or RNase. We
found that the supernatant heated to 50 °C, but not 75 °C and
100 °C, retained its ability to induce cleavage of caspase-1 and
GSDMD, secretion of IL-1β and IL-18, and cell death in WT
BMDMs (Supplementary Fig. 2a, b). Further, the supernatant
treated with proteinase K did not lead to activation of caspase-1,
cleavage of GSDMD, secretion of IL-1β and IL-18, and cell death
in WT BMDMs, whereas treatment of DNase or RNase did not
affect the ability of the supernatant to induce inﬂammasome
responses (Supplementary Fig. 2c, d). To deduce the molecular
size of the secreted factor, we used ﬁlter-mediated size-fractio-
nation techniques to separate the supernatant of ΔHbl B. cereus
into different molecular-sized fractions. We found that the
supernatant fractions of >9 kDa, >30 kDa, and <50 kDa, but not
fractions of <9 kDa, <30 kDa, and >50 kDa, potentiated activation
of the inﬂammasome (Supplementary Figs. 2e, f). These ﬁndings
indicate that a heat-labile proteinaceous factor of 30–50 kDa
secreted by ΔHbl B. cereus is a potent activator of the
inﬂammasome.
NHE activates the NLRP3 inﬂammasome. We previously
excluded a contribution from NHE in driving the early inﬂam-
masome response owing to a role for HBL31. However, toxins
have different kinetics and assembly processes, which determine
their activity39. Therefore, we reasoned that NHE could have been
overlooked as a potential candidate34. This idea is supported by
our ﬁnding that another 30–50 kDa secreted factor is acting in a
non-redundant manner in the activation of the NLRP3 inﬂam-
masome during B. cereus infection (Supplementary Fig. 2e, f), and
that NHE is comprised of three subunits, called A, B, and C, all of
which are of 30–50 kDa in size40–43.
To this end, we neutralized the supernatant of WT B. cereus with
antibodies against NHE and/or HBL and stimulated WT BMDMs
with the supernatant overnight. We found that neutralization of
both NHE and HBL, but not NHE or HBL alone, abolished the
ability of the supernatant to induce activation of caspase-1, cleavage
of GSDMD, secretion of IL-1β and IL-18, and pyroptosis in WT
BMDMs (Fig. 3a–e). Further, neutralization of NHE abrogated the
ability of the supernatant of ΔHbl B. cereus to induce activation of
caspase-1, cleavage of GSDMD, secretion of IL-1β and IL-18, and
pyroptosis in WT BMDMs (Fig. 3f–j). Conversely, neutralization of
HBL abolished the ability of ΔNhe B. cereus to elicit inﬂammasome
responses in WT BMDMs (Fig. 3f–j). Neutralization of the
supernatant with antibodies against either or both NHE and HBL
did not affect the secretion of TNF and KC in BMDMs (Fig. 3e, j
and Supplementary Fig. 2g, h), suggesting that secretion of
inﬂammasome-independent cytokines was not compromised in
response to supernatant treated with neutralizing antibodies. These
data revealed that, in addition to blockade of HBL, abrogation of
NHE by means of neutralization or genetic deletion prevented
cytosolic inﬂammasome sensing of B. cereus infection.
To investigate further, we expressed the three recombinant
subunits, which comprise NHE: subunit A (41 kDa), subunit
B (40 kDa), and subunit C (37 kDa)43. Treatment with recombinant
NHE, but not individual subunits, resulted in robust activation of
inﬂammasome responses in LPS-primed WT BMDMs but not in
LPS-primed Nlrp3–/– BMDMs (Fig. 4a, b). Importantly, treatment
of LPS-primed WT and Casp11–/– BMDMs with NHE resulted in
inﬂammasome activation (Supplementary Fig. 3a, b), indicating that
NHE-induced inﬂammasome responses were not owing to NHE-
mediated translocation of extracellular LPS into the cytoplasm to
activate the caspase-11-NLRP3 pathway. Further, NHE-induced
ASC speck formation in WT BMDMs but not in Nlrp3–/– BMDMs,
whereas dsDNA poly(dA:dT) induced ASC speck formation in both
WT and Nlrp3–/– BMDMs (Fig. 4c). In addition, we observed that
in response to NHE, BMDMs lacking the full pore-forming ability
of the pyroptotic factor GSDMD (GsdmdI105N/I105N)10,44,45 had an
impaired ability to secrete IL-1β and IL-18 and undergo cell death
at 1 and 2 h, compared with WT BMDMs (Supplementary Fig. 3c,
d). Electron microscopy analyses revealed that stimulation with
NHE led to a disruption of cellular morphology and architecture in
BMDMs (Fig. 4d and Supplementary Fig. 3e). Further, we found
that NHE-induced secretion of IL-1β and IL-18 and led to cell death
in human THP-1 monocytes, and that this response was impaired
following inhibition of NLRP3 by MCC950 (Supplementary Fig. 3f).
These ﬁndings highlight that NHE is a non-redundant toxin driving
activation of the NLRP3 inﬂammasome during B. cereus infection,
and that innate immune recognition of NHE by the NLRP3
inﬂammasome is functionally conserved between mice and
humans.
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NHE assembles in a linear order on the plasma membrane. The
tripartite composition of NHE suggests that an important
assembly process must occur in order to exert the full activity of
this toxin. Indeed, we found that individual components of NHE
or all possible combinations of two of the three components of
NHE did not trigger activation of the NLRP3 inﬂammasome
(Figs. 4a, b and 5a, b), suggesting that all three subunits of NHE
are essential in eliciting activation of the NLRP3 inﬂammasome.
An earlier study reported that the B subunit is the binding
component of the NHE complex on Vero cells41. A later study
found that both the B and C subunits can bind to Vero cells,
whereas the A subunit exerts cytotoxic effects in these cells42. A
further study revealed that the C subunit initiates binding on
Chinese Hamster Ovary cells43.
To investigate whether a speciﬁed order of assembly of NHE
components leads to activation of the NLRP3 inﬂammasome in
BMDMs, we stimulated WT BMDMs either with A, B, or C for
30 min, followed by extensive washing to remove unbound
subunits prior to addition of the remaining subunits. We
observed that C→A+ B (where the arrow symbol indicates a
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Fig. 2 The secreted factor of B. cereus activates the NLRP3 inﬂammasome. a, Immunoblot analysis of caspase-1, gasdermin D, and GAPDH (loading
control) in WT or mutant BMDMs left untreated or LPS-primed and assessed 20 h after stimulation with ΔHbl supernatant, or after infection with ΔHbl
(m.o.i. of 5). b Release of IL-1β, IL-18, and TNF and death of BMDMs after treatment as in a. c Brightﬁeld microscopy analysis of BMDMs 8 h after
stimulation as in a. d Immunoﬂuorescent analysis of ASC speck formation (red) in BMDMs after treatment as in a. Quantiﬁcation of the prevalence of ASC
specks is shown on the right as a percentage of total cells (DAPI). At least 200 cells from each genotype were assessed. Scale bar, 25 μm c, d. Arrowheads
indicate pyroptotic cells c or ASC specks d. NS, not signiﬁcant, ****P < 0.0001 (one-way ANOVA with Dunnett’s multiple-comparisons test b or student’s
unpaired t test d). Each symbol represents an independent experiment b, d. Data are representative of three independent experiments (n= 3, a–d; mean
and s.e.m. in b, d). Source data are provided as a Source Data ﬁle.
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washing step and the plus symbol indicates subunits added in
concert) induced activation of caspase-1, secretion of IL-1β and
IL-18, and pyroptosis (Fig. 5c, d). The order of A→B+ C or
B→A+ C did not trigger inﬂammasome responses (Fig. 5c, d).
These data suggest that C is the apical binding subunit.
To elucidate the precise order of subunit assembly, leading
to inﬂammasome activation, we treated the WT BMDMs
with individual components in the order of C→A→B or
C→B→A. We identiﬁed that the order of C→B→A led to
activation of caspase-1, secretion of IL-1β and IL-18, and
pyroptosis (Fig. 5e, f). These ﬁndings demonstrate that
individual subunits of NHE follow a speciﬁc and linear order
of NHE complex assembly to induce effective engagement of
the NLRP3 inﬂammasome.
NHE induces activation of NLRP3 via the efﬂux of K+. To
assess whether NHE is maintained on the plasma membrane,
leading to activation of the NLRP3 inﬂammasome, we treated
WT BMDMs with NHE and performed immunoﬂuorescence
staining using antibodies against individual subunits of NHE.
Immunoﬂuorescence staining techniques revealed that all three
subunits of NHE colocalized with the cell surface marker CD11b
of BMDMs, suggesting that NHE localizes on the plasma mem-
brane (Supplementary Fig. 4a–c). Further, we separated the cell
membrane and cytosolic fractions of BMDMs stimulated with the
supernatant of ΔHbl B. cereus and found all three subunits of
NHE in the membrane fraction (Supplementary Fig. 4d). In
addition, inhibition of phagocytosis using the inhibitor cytocha-
lasin B or cytochalasin D did not impede the ability of NHE, the
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supernatant of ΔHbl B. cereus, or live ΔHbl B. cereus to induce
activation of the inﬂammasome in WT BMDMs (Supplementary
Fig. 5a–d). These results indicate that internalization of NHE into
BMDMs is not required to drive inﬂammasome activation.
Indeed, transfection of NHE subunits into WT BMDMs did not
trigger inﬂammasome activation, whereas transfection of ﬂagellin
triggered activation of the inﬂammasome (Supplementary Fig. 5e,
f). These data suggest that localization of NHE on the plasma
membrane is sufﬁcient to induce activation of the inﬂammasome.
The localization of NHE implies that the mechanism driving
activation of the NLRP3 inﬂammasome might emanate from the
plasma membrane. NLRP3 is activated by membrane-induced
cellular perturbations via pathways dependent on K+ efﬂux or
independent of K+ efﬂux46–50. To investigate the role of K+
efﬂux in NHE-induced activation of the inﬂammasome, we used
inductively coupled plasma-optical emission spectroscopy (ICP-
OES) to measure the cytosolic concentration of K+ in WT
BMDMs stimulated with NHE. The level of cytosolic concentra-
tion of K+ in BMDMs treated with NHE decreased substantially
compared with untreated BMDMs, a reduction which is similar
to that seen in BMDMs treated with the classical NLRP3 activator
LPS+ATP (Fig. 5g). To conﬁrm this observation, we added KCl
into the cell culture media prior to addition of NHE. We observed
that addition of extracellular K+ inhibited activation of the
inﬂammasome in response to NHE, the supernatant of ΔHbl B.
cereus, ΔHbl B. cereus, or LPS+ATP (Fig. 5h, i and Supplemen-
tary Fig. 6a, b). Further, we observed no difference in the cytosolic
concentration of Na+ in BMDMs treated with NHE or LPS+
ATP compared with untreated BMDMs (Supplementary Fig. 6c),
and that addition of extracellular Na+ did not inhibit activation
of the inﬂammasome in response to NHE or LPS+ATP
(Supplementary Fig. 6d, e). These data suggest that localization
of NHE on the plasma membrane is sufﬁcient to induce
activation of the inﬂammasome via efﬂux of K+.
NHE forms pores in the lipid bilayer and is cytotoxic. Given
that NHE subunits localize on the mammalian plasma membrane
and induce K+ efﬂux, we hypothesized that NHE might be able to
create a membrane pore, destabilizing the plasma membrane of
BMDMs. To test this possibility, we formulated liposomes com-
posed of the lipid species DPPC, DSPC and DOPC, and choles-
terol, which mimic the mammalian plasma membrane51. These
liposomes contain an internal aqueous methylene blue dye, which
when released can be captured by dye-capturing resins (Fig. 6a).
Addition of NHE, but not individual components of NHE, heat-
inactivated NHE, or bovine serum albumin resulted in the release
of dye from the liposomes (Fig. 6b, c). The level of dye leakage
induced by NHE was similar to that of HBL or sonication of the
liposomes (Fig. 6b, c). Further, incubation of NHE with liposomes
inhibited the ability of NHE to induce inﬂammasome responses
in BMDMs (Fig. 6d, e), suggesting potential sequestration of NHE
on the membrane of the liposome.
Under cryo-transmission electron microscopy (Cryo-TEM), we
observed distinct pores in the membrane of liposomes treated
with NHE (Fig. 6f). The ability of NHE to insert into the
membrane suggests that this toxin could kill different cell types
from different host species. To this end, we treated immune and
non-immune cells with NHE and found that NHE-induced cell
death in all cell types tested, including those from humans, mice,
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treatment with NHE component added in various orders. d, f Release of IL-1β and IL-18, and death of WT BMDMs as treated in c and e. g Inductively
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monkeys, and dogs (Fig. 7a, b). To further explore the dynamics
of NHE-induced cell death, we treated BMDMs with NHE and
examined cell viability kinetics using IncuCyte assays. A lower
concentration of 100 nM NHE-induced activation of caspase-1,
cleavage of GSDMD and pro-IL-1β, secretion of IL-1β and IL-18,
and cell death in WT BMDMs, but not in Nlrp3–/– BMDMs
(Supplementary Fig. 7a–c). However, a higher concentration of
500 nM NHE-induced rapid cell death in both WT and Nlrp3–/–
BMDMs within 20 min, but was unable to induce inﬂammasome
responses (Supplementary Fig. 7a–c). Accumulation of NHE
pores on the plasma membrane of BMDMs would mediate
membrane rupture independently of the inﬂammasome, which
provides an explanation for the mechanism of cell death in cell
types which do not express inﬂammasome components (Fig. 7a,
b). Taken together, these ﬁndings indicate that NHE induces pore
formation in the cell membrane and can induce cytotoxic effects
across multiple cell types and host species dictated by the
bioavailability of the toxin.
The putative transmembrane region of NHE-C is essential. Our
data suggested that NHE is localized to the plasma membrane of
macrophages and that the C subunit of NHE is the apical subunit
binding the plasma membrane. Bioinformatic analysis of the
protein sequence of the C subunit of NHE revealed the presence
of a putative transmembrane region between amino-acid posi-
tions 228 and 250 (Supplementary Fig. 8a, b), consistent with
previous studies52,53. We hypothesized that deletion of the
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putative transmembrane region in this subunit would abolish the
ability of NHE to bind the plasma membrane and induce acti-
vation of the inﬂammasome. To address this hypothesis, we
expressed the C subunit with and without the putative trans-
membrane region (Supplementary Fig. 8c). Next, we treated WT
BMDMs with WT NHE (designated as NHEWT, carrying all the
three WT subunits) or mutant NHE (designated as NHEmut.,
where the WT C subunit is replaced with the mutant C subunit).
We found that NHEWT induced K+ efﬂux, activation of caspase-
1, secretion of IL-1β and IL-18, and pyroptosis, whereas NHEmut.
did not (Fig. 8a–c). This observation was not owing to differences
in secondary structures between the WT C subunit and mutant
C subunit as shown by circular dichroism analysis (Fig. 8d).
Further, IncuCyte, scanning electron microscopy, and transmis-
sion electron microscopy analyses collectively revealed that
BMDMs treated with NHEWT, but not NHEmut., underwent cell
death (Fig. 8e, f and Supplementary Fig. 9a, b).
To assess the membrane-binding ability of the mutant
C subunit, WT BMDMs were treated either with NHEWT or
NHEmut. followed by fractionation of the membrane and cytosolic
compartments. All three subunits of NHE were found in the
membrane fraction of BMDMs treated with NHEWT, whereas
none of the NHE subunits were detected in the membrane
fraction of BMDMs treated with NHEmut. (Fig. 9a). Confocal
microscopy techniques revealed that although the WT C subunit
colocalized with CD11b on the plasma membrane, the mutant
C subunit was unable to do so (Fig. 9b). Furthermore, we found
that liposomes treated with NHEWT underwent leakage of the
dye, whereas liposomes treated with NHEmut. did not (Fig. 9c).
Cryo-TEM analysis conﬁrmed that liposomes treated with
NHEWT had membrane pores, whereas liposomes treated with
NHEmut. were largely intact (Fig. 9d). Like NHE-C, the apical
binding subunit of HBL, HBL-B, also carries a corresponding
putative transmembrane region31,54. Importantly, deletion of the
putative transmembrane region of HBL-B did not affect the
secondary structure or the ability of this subunit to bind to the
cell membrane of BMDMs (Supplementary Fig. 10a–d), suggest-
ing a functional divergence of these putative transmembrane
regions between the two toxins. These data collectively suggest
that the putative transmembrane region of the C subunit of NHE
might be important in mediating membrane binding and pore
formation, leading to activation of the inﬂammasome.
NHE induces inﬂammasome-mediated inﬂammation in the
host. Given that NHE induces activation of the NLRP3 inﬂam-
masome in primary macrophages, we speculated that this toxin
might induce activation of the NLRP3 inﬂammasome in the host.
To test this idea, WT mice were administered with the super-
natant of B. cereus or supernatant that had been neutralized
against NHE, HBL, or both NHE and HBL. We observed that
neutralization of both NHE and HBL abolished the ability of the
supernatant to induce elevated amounts of IL-18 in the serum
and peritoneal ﬂuid of WT mice (Fig. 10a, b). Neutralization of
either NHE or HBL alone led to some reduction in the secretion
of IL-18 compared with isotype-treated controls; however, this
reduction was less substantial compared to neutralization of both
NHE and HBL (Fig. 10a, b). This ﬁnding suggests a potential
synergistic effect of the two toxins in driving inﬂammasome
responses. To validate that secretion of IL-18 was speciﬁc to NHE,
WT mice were administered with the supernatant of ΔHbl
B. cereus, which had been neutralized with antibodies against
NHE or with an IgG isotype. Indeed, neutralization of NHE
impaired the ability of the supernatant of ΔHbl B. cereus to
induce secretion of IL-18 in WT mice compared with the cor-
responding control-treated supernatant (Fig. 10c, d).
To conﬁrm a role for the NLRP3 inﬂammasome, we infected
WT, Nlrp3–/–, Casp1/11–/–, and GsdmdI105N/I105N mice with ΔHbl
B. cereus and analyzed the levels of IL-18 in the circulation and
peritoneal cavity. These analyses revealed that WT mice
had elevated levels of IL-18, whereas Nlrp3–/–, Casp1/11–/–, and
GsdmdI105N/I105N mice had reduced levels of IL-18 in response to
ΔHbl B. cereus infection (Fig. 10e, f). We speculate that the
residual levels of IL-18 observed in Nlrp3–/– and GsdmdI105N/I105N
mice might be due to contributions from another inﬂammasome
sensor or pyroptotic effector, respectively. Furthermore, pharma-
cological inhibition of the NLRP3 inﬂammasome with
MCC950 attenuated secretion of IL-18 in the circulation and the
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peritoneal cavity of mice infected with ΔHbl B. cereus (Fig. 10g, h).
Together, these data indicate that recognition of NHE via the
NLRP3 inﬂammasome provides another layer of innate immune
mechanism in triggering inﬂammation in the host in response to
B. cereus infection. The functional conservation between the
mechanism of action of NHE and HBL is exploited by NLRP3 to
ensure effective host recognition of the genetically diverse family
of B. cereus strains, which express either one or both toxins.
Discussion
B. cereus is a Gram-positive bacterium that causes gastrointestinal
and extra-gastrointestinal pathologies in humans1. Our study
reveals that cytosolic recognition of B. cereus infection by the host
relies on exploitation of the conserved mechanism of action of two
different toxins produced by the same bacterium (Supplementary
Fig. 11a–c). Importantly, our results further suggest that NLRP3
might potentially exploit the functional and structural similarity of
many other PAMPs. Studies have reported that NHE is found in
95–98% of the clinical, food, and environmental isolates of B. cer-
eus31,55,56, and that HBL is found in 40–92% of the iso-
lates31,55,57,58. The prevalence of NHE and HBL suggests that both
toxins are key virulence factors important for the pathogenesis of B.
cereus infection. Further, these epidemiological data give rise to
scenarios that some strains might express NHE or HBL, or both
NHE and HBL. We reasoned that the ability of macrophages to
detect both toxins allows the host to respond to any naturally-
occurring pathogenic variants and that a single NLR protein is able
to sense any variants expressing at least one of the two toxins, or to
sense strains that have phase-variable expression of the two toxins.
An alternative perspective is that the expression of multiple func-
tionally analogous toxins from the same bacterium is essential for
infection in the host. Indeed, these toxins might be required for
acquisition of nutrients and/or the destruction of immune cells
during B. cereus infection. If this were not the case, it would have
been evolutionarily advantageous to downregulate the expression of
these toxins or removing these toxins altogether as a mechanism to
avoid innate immune recognition.
The functional and structural similarity of NHE and HBL
exploited by NLRP3 is based on pore formation and the permis-
siveness of the pore to K+ efﬂux. The ability of NHE to induce K+
efﬂux aligned with previous ﬁndings, suggesting that NHE induces
the formation of large conducting openings that are permeable to
cations52,59. Previous studies have classiﬁed NHE as a member of
e
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Fig. 8 The transmembrane domain in NHE-C is essential for inﬂammasome activation and cell death. a Immunoblot analysis of caspase-1 of WT or
Nlrp3−/− BMDMs left untreated (Med.) or LPS-primed and assessed 3 h after treatment with C+ B+A (NHEWT) or Cmut.+ B+A (NHEmut.). b Release of
IL-1β and IL-18, and death of WT or Nlrp3−/− BMDMs as treated in a. c Inductively coupled plasma-optical emission spectrometry analysis of intracellular
concentrations of K+ of BMDMs left untreated or assessed 3 h after treatment with NHEWT or NHEmut.. d Circular dichroism analysis of the secondary
structures of CWT or Cmut.. e IncuCyte live-imaging analysis of the viability of WT BMDMs left untreated or LPS-primed and assessed after treatment with
NHEWT or NHEmut.. f Scanning electron microscopy analysis of WT BMDMs left untreated or LPS-primed and assessed 3 h after treatment with NHEWT or
NHEmut.. Scale bar, 2 μm f. NS, not signiﬁcant, ***P < 0.001 and ****P < 0.0001 (one-way ANOVA with Dunnett’s multiple-comparisons test b, c or
Student’s unpaired t test e). Each symbol represents an independent experiment b, c, and e. Data are representative of three independent experiments
(n= 3 in a–c, e, and f; n= 1 in d; mean and s.e.m. in b, c, and e. Source data are provided as a Source Data ﬁle.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14534-3
10 NATURE COMMUNICATIONS |          (2020) 11:760 | https://doi.org/10.1038/s41467-020-14534-3 | www.nature.com/naturecommunications
the α-helical pore-forming toxin family; members of which are
characterized by the presence of an α-helical hydrophobic
membrane-integrative region52,53. We observed that deletion of this
hydrophobic region impairs the ability of subunit C to bind to
membrane (Supplementary Fig. 11b), highlighting that the hydro-
phobic region in subunit C might be responsible for anchoring to
the host membrane, similar to that observed in cytolysin A of the α-
helical pore-forming toxin family60,61. These ﬁndings are consistent
with a previous study, reporting that deletion of the same hydro-
phobic region in subunit C leads to a loss of cytotoxicity of NHE on
Vero cells42. We postulate that the anchorage mediated by the
hydrophobic region in subunit C can also function to initiate a
series of conformational changes in subunit C, triggering recruit-
ment of subunit B and subunit A for the ﬁnal construction of the
NHE pore complex. Although the NHE and HBL pores are both
permissive to efﬂux of K+, subtle differences in the mechanism of
action between the two toxins have been observed. Unlike subunit
C of NHE, we found that deletion of the corresponding hydro-
phobic region of HBL-B, which is the apical subunit of HBL31, does
not impair the ability of the subunit to bind the plasma membrane.
It is possible that the hydrophobic region of HBL-B is not essential
for membrane binding and that deletion of this region reduces
steric hinderance to expose the bona ﬁde-binding region/s of HBL-
B, enhancing binding of HBL-B to the plasma membrane.
Targeting the conserved activity of bacterial pore-forming
toxins might be efﬁcacious against certain bacterial pathogens.
For example, neutralization of the activity of the pore-forming
toxin haemolysin A of S. aureus62,63 and the anthrax toxin of B.
anthracis64,65, have been effective. These ﬁndings are of clinical
importance given the increasing incidence of antibiotic-resistant
bacteria, including B. cereus1,66. Therefore, a better understanding
of the host defence strategy against B. cereus infection will be
beneﬁcial and neutralization of toxins might complement current
therapies against infection caused by toxin-producing bacteria. In
conclusion, we identiﬁed that the functional similarity and con-
served mechanism of action of two multicomponent toxins of
B. cereus is exploited for innate immune sensing by an inﬂam-
masome sensor protein. Further studies are required to under-
stand whether NHE and HBL might target any cell surface
receptor/s for binding to the plasma membrane.
Methods
Mice. C57BL/6 mice and GsdmdI105N/I105N mice10 were sourced from The Aus-
tralian National University. Nlrp3–/– 67, Casp1/11–/– 68, and Casp11–/– 69 mice were
sourced from The Jackson Laboratory. Nlrc4–/– 70 and Asc–/– 70 mice were sourced
from the University of Queensland. Aim2–/– mice71 were sourced from Genentech.
All mice are on, or backcrossed to, the C57BL/6 background for at least 10 gen-
erations. Male and female mice of 6–8 weeks old were used. Mice were bred and
maintained at The Australian National University under speciﬁc pathogen-free
conditions. All animal studies were conducted in accordance with the Protocol
Number A2017/05 approved by The Australian National University Animal
Experimentation Ethics Committee.
BMDMs. Primary BMDMs were cultured for 6 days in Dulbecco's Modiﬁed
Eagle Medium (DMEM) (11995073, ThermoFisher Scientiﬁc) supplemented
with 10% fetal bovine serum (FBS; F8192, Sigma), 30% L929-conditioned media
and 1% penicillin and streptomycin (10378016, Gibco ThermoFisher)72. BMDMs
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were seeded in antibiotic-free media at a concentration of 1 × 106 cells per well in
12-well plates.
Cell lines. CaCo-2 cells were cultured for 3 days in Eagle’s Minimum Essential
Medium (EMEM) (670086, ThermoFisher Scientiﬁc) supplemented with 20% FBS,
and 1% penicillin and streptomycin. CT26, Jurkat, RMA-S, and THP-1 cells were
cultured for 3 days in Rosewell Park Memorial Institute (RPMI)-1640 (11875093,
ThermoFisher Scientiﬁc) supplemented with 10% FBS, and 1% penicillin and strep-
tomycin. HEK293T and HT-29 cells were cultured for 3 days in DMEM supple-
mented with 10% FBS, and 1% penicillin and streptomycin. L929, LS 174 T, MDCK,
and Vero cells were cultured for 3 days in EMEM supplemented with 10% FBS, and
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1% penicillin and streptomycin. K-562 cells were cultured for 3 days in Iscove's
Modiﬁed Dulbecco's Medium (IMDM) (12440053, ThermoFisher Scientiﬁc) sup-
plemented with 10% FBS, and 1% penicillin and streptomycin. MC-38 cells were
cultured for 3 days in DMEM supplemented with 10% FBS, 1% non-essential amino
acids (11140050, Gibco ThermoFisher), 1% 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES; 15630080, Gibco ThermoFisher), and 1% penicillin
and streptomycin. MutuDCs were cultured for 3 days in IMDM supplemented with
10% FBS, 1% sodium bicarbonate (25080094, Gibco ThermoFisher), 1% HEPES, and
1% penicillin and streptomycin. U266B1 cells were cultured for 3 days in RPMI
supplemented with 15% FBS, and 1% penicillin and streptomycin. Cells were seeded
in antibiotic-free media at a concentration of 0.5 × 106 cells per well in 24-well plates.
Bacterial culture. B. cereus was grown in Luria-Bertani (LB) media (244620, BD)
overnight under aerobic conditions at 30 °C31. The Bacillus strains used in this
study are listed in Supplementary Table 1. Salmonella enterica serovar Typhi-
murium was grown in LB media overnight under aerobic conditions at 37 °C. The
next day, all bacteria were subcultured (1:10) in fresh media for 3-4 h.
Stimulation of BMDMs with bacteria and inﬂammasome activators. Unprimed
BMDMs were infected with WT or ΔHbl B. cereus at multiplicity of infection
(m.o.i.) of 2–5 for 3–20 h for inﬂammasome activation; BMDMs were infected with
ΔHbl B. cereus at m.o.i. of 2 for 0-60 min for pIkB, IkB, pERK, ERK, NLRP3, and
GAPDH protein levels. To activate the canonical NLRP3 inﬂammasome, BMDMs
were primed with 500 ng/ml ultrapure LPS from E. coli (ALX-581-014-L002,
Enzo Life Sciences) for 4 h and stimulated with 5 mM ATP (10127531001, Roche)
for 45 min. To activate the NLRC4 inﬂammasome, BMDMs were infected with
S. Typhimurium at m.o.i. of 2 for 4 h. Ultrapure ﬂagellin was mixed with 20 μl of
the liposomal transfection reagent 1,2-Dioleoyl-3-trimethylammonium propane
(DOTAP) (11202375001, Sigma) in phosphate-buffered saline (PBS). After 30 min,
the complexes were added to LPS-primed BMDMs in Hank’s Balanced Salt
Solution (HBSS, H9394, Sigma) and incubated for 3–5 h. To activate the AIM2
inﬂammasome, 2.5 μg of poly(dA:dT) (tlrl-patn, InvivoGen) were resuspended in
PBS and mixed with 0.3 μl of Xfect polymer in Xfect reaction buffer (631318,
Clontech Laboratories, Inc.). After 30 min, DNA complexes were added to BMDMs
in Opti-MEM (31985-070, ThermoFisher Scientiﬁc) and left stimulated for 4 h. To
activate caspase-11, 5 μg of LPS was transfected as described for poly(dA:dT)
transfection. For inhibition studies, 50 μM of cytochalasin B (C6762, Sigma), 50 μM
of cytochalasin D (C8273, Sigma), 20 μM of the selective and potent NLRP3
inhibitor, MCC95036–38, 50 mM of potassium chloride (KCl) (P9541, Sigma) or
50 mM of sodium chloride (NaCl) (S9888, Sigma) were added to BMDMs 30 min
prior to stimulation. Cell culture supernatants were collected for enzyme-linked
immunosorbent assay (ELISA) and lactate dehydrogenase assays. Cell culture
supernatants and cell lysates were collected for immunoblot analysis.
Stimulation of BMDMs with bacterial supernatant. The overnight bacterial
culture was centrifuged at 4000 × g for 10 min. The supernatant was ﬁlter-sterilized
using low-protein-binding 0.45-μm ﬁlters (SLHV033RS, Merck). For size-fractio-
nation, the supernatant of ΔHbl B. cereus was fractionated using spin-ﬁlter col-
umns of the 9 kDa (89884 A, ThermoFisher Scientiﬁc), 30 kDa (UFC803096,
Millipore), or 50 kDa range (UFC905096, Millipore). For heat inactivation, the
supernatant of ΔHbl B. cereus was heated to 50 °C, 75 °C or 100 °C for 10 min. To
remove proteins, DNA or RNA, the supernatant of ΔHbl B. cereus was pre-treated
with Proteinase K (1 mg/ml, 19133, Qiagen), DNase I (1 mg/ml, Roche), or RNase
A (1 mg/ml, Qiagen), respectively, for 1 h. In all, 50–150 μl of bacterial supernatant
were added to LPS-primed BMDMs.
For neutralization studies, the supernatant from various B. cereus strains was
treated with antibodies against NHE (2 μl of 0.8 mg/ml α-NHE-B), HBL (2 μl 0.8
mg/ml α-HBL-L2), or combination of NHE (2 μl of 0.8 mg/ml α-NHE-B) and HBL
(2 μl 0.8 mg/ml α-HBL-L2) for 1 h before addition to LPS-primed BMDMs43,55. For
controls, mouse isotype IgG1 (2 μl, 5415, Cell Signaling Technologies) was used.
Cloning, protein expression and puriﬁcation. Putative transmembrane regions in
individual component of NHE were predicted using the software Membrane
Protein Explorer server, also known as MPEx73. Helical wheel diagrams were
constructed using the HELIQUEST server74. DNA sequences of the gene encoding
NHE-C and HBL-B were acquired from the genome of B. cereus NVH 1230-88
(GenBank: CAB53340.2) and B. cereus strain ATCC 10876 (GenBank:
CM000715.1) respectively, and were submitted to GenScript for cloning. In brief,
DNA sequences encoding NHE-C and HBL-B with and without their putative
transmembrane region were cloned into NcoI and XhoI restriction sites of the
pET-28a(+)-TEV plasmid containing kanamycin resistance. The BL21(DE3) E. coli
strain (C600003, ThermoFisher Scientiﬁc) was transformed with the pET-28a
(+)-TEV plasmid vector. A single colony was picked to inoculate a starter culture
of 10 mL LBKan broth (LB broth+ 30 μg/ml kanamycin (10106801001, Roche)),
which was incubated at 37 °C, shaking (180 rpm) overnight. After overnight
incubation, 10 mL of starter culture was transferred into 1 L of LBKan broth and
incubated at 37 °C, shaking (180 rpm) for 4 h until an OD600 of 0.6 was obtained.
Expression was induced by adding isopropyl β-D-1-thiogalactopyranoside (1 mM;
IPTG, Roche) and the incubation continued under identical conditions overnight.
The culture suspension was centrifuged (5000 × g, 20 min, 4 °C) to pellet the
bacteria and stored at −80 °C until required. The cell pellet was resuspended in
lysis buffer (50 mM Tris, pH 8.0 (BP152-1, ThermoFisher Scientiﬁc); 300 mM NaCl
(SA046, Chem-Supply); 5 mM imidazole (I2399, Sigma-Aldrich); 250 μg/ml lyso-
zyme (89833, ThermoFisher Scientiﬁc); and 1 mM phenylmethylsulfonyl ﬂuoride
(78830, Sigma-Aldrich)). Cells were subsequently disrupted by sonication and
centrifuged (27,000 × g, 20 min, 4 °C). The supernatant was passed through a 0.22
µm ﬁlter (SLGP033RS, Merck). The C-terminal hexa-His-tagged proteins were
puriﬁed by using HisTrap HP histidine-tagged protein puriﬁcation column
(17524701, GE Healthcare Lifesciences) at 4 °C using the NGC Quest 10 Chro-
matography System (7880001, BioRad) and ChromLab software (BioRad). The
target proteins were eluted from the HisTrap column using a stepwise gradient
of imidazole (10% increments) from Buffer A (50 mM Tris, pH 8.0; 300 mM NaCl;
5 mM imidazole) to Buffer B (50 mM Tris, pH 8.0; 300 mM NaCl; 500 mM imi-
dazole). Purity of the eluted proteins was analyzed by SDS-PAGE and Coomassie
blue staining. The protein concentration was determined by spectrophotometric
measurements of A280 using a NanoDrop 2000/2000c spectrophotometer.
Circular dichroism measurement. The circular dichroism spectrum (θ) was
recorded at 2 nm/s scanning speed on a Chirascan V100 Circular Dichroism
Spectrometer from 200 to 250 nm at 25 °C. The mean residue ellipticity was cal-
culated and the spectra are shown as an average of three scans.
Stimulation of BMDMs with recombinant NHE and HBL. LPS-primed BMDMs
were stimulated with all three NHE or HBL components, individually or in various
combinations (NHE: 100 nM, HBL: 5 nM and 1–3 h for caspase-1 activation). For
binding order studies, LPS-primed BMDMs were stimulated with a single NHE
component (either A, or B, or C) for 1 h. This step was followed by extensive washing
(denoted by:→) with PBS three times to remove unbound toxin. The two remaining
components were added in concert (denoted by: +), or the second individual com-
ponent was added for 1 h followed by the third individual component, with washing
steps in between. For transfection of NHE, each reaction consisted of individual NHE
components (100 nM each) or a combination of two components (50 nM each)
mixed with 10 µl of the liposomal transfection reagent DOTAP. After 30min the
complexes were added to LPS-primed BMDMs in HBSS and left for 3 h.
Liposome studies. Liposomes were synthesized31 and treated with NHE (30 nM),
individual NHE component (30 nM), heat-inactivated NHE, HBL (0.5 µM), a protein
buffer used to carry NHE and HBL (10mM Tris HCl, 0.5mM ethylenediaminete-
traacetic acid (pH 8.0)), or bovine serum albumin (BSA) (1 μg/ml; 001000173,
Jackson ImmunoResearch) or NHEmut. (30 nM). The liposomes were sonicated at 100
amplitude for 5 mins as control (CTRL). The released dye was captured by a cation
Fig. 10 NHE induces activation of the NLRP3 inﬂammasome in the host. a Concentration of IL-18 in the serum of WT mice assessed 16 h after
intraperitoneal injection with 200 μl of supernatant of WT B. cereus (Sup.), which had been treated with either an isotype control, anti-HBL-neutralizing
antibodies (α-HBL), anti-NHE-neutralizing antibodies (α-NHE), or both (α-Tox.). b Concentration of IL-18 in the peritoneal ﬂuid of WT mice assessed 1 h
after intraperitoneal injection with treatment as in a. c Concentration of IL-18 in the serum of WT mice assessed 16 h after intraperitoneal injection with
200 μl ΔHbl B. cereus supernatant, which had been treated with either an isotype control or anti-NHE-neutralizing antibodies (α-NHE). d Concentration
of IL-18 in the peritoneal ﬂuid of WT mice assessed 1 h after intraperitoneal injection with treatment as in c. e Concentration of IL-18 in the serum of WT,
Nlrp3−/−, Casp1/11−/− or GsdmdI105N/I105N mice assessed 6 h after intraperitoneal injection with 5 × 106 CFU of ΔHbl B. cereus (ΔHbl). f Concentration
of IL-18 in the peritoneal ﬂuid of WT, Nlrp3−/−, Casp1/11−/−, or GsdmdI105N/I105N mice assessed 6 h after intraperitoneal injection with treatment as in e.
g Concentration of IL-18 in the serum of WT mice administered with either PBS or MCC950, both intraperitoneally, followed by intraperitoneal infection
with 5 × 106 CFU of ΔHbl with a corresponding second dose of PBS or MCC950, 6 h after infection. h Concentration of IL-18 in the peritoneal ﬂuid of WT
mice administered with either PBS or MCC950 (as in g) 6 h after infection with 5 × 106 CFU of ΔHbl. **P < 0.01, ***P < 0.001, and ****P < 0.0001 (one-way
ANOVA with Dunnett’s multiple-comparisons test a, b, e, and f or Student’s unpaired t test c, d, g, and h. Each symbol represents an individual mouse a–h.
Data are pooled from two independent experiments (n= 2 in a–h; mean and s.e.m. in a–h). Source data are provided as a Source Data ﬁle.
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exchanger resin Dowex (10–15mg per well). The absorbance (OD) of residual dye
was measured at a wavelength of 595 nm using the Inﬁnite 200 PRO system (Tecan).
To investigate the capacity of liposomes to inhibit NHE-induced activation of the
inﬂammasome, recombinant NHE (100 nM) was left untreated or treated with
liposomes (7mM) for 1 h, prior to addition to LPS-primed BMDMs.
Immunoblotting analysis. For caspase-1 immunoblotting, BMDMs and super-
natant were lysed in lysis buffer and sample loading buffer containing sodium
dodecyl sulphate (SDS) and 100 mM dithiothreitol (DTT). For immunoblotting of
pIkB, IkB, pERK, ERK, NLRP3, and GAPDH, the supernatant was removed and
BMDMs were washed once with PBS, followed by lysis in radio-
immunoprecipitation buffer and sample loading buffer containing SDS and
100 mM DTT. Proteins were separated on 8–12% polyacrylamide gels. Following
electrophoretic transfer of proteins onto polyvinyldiﬂuoride (PVDF) membranes
(IPVH00010, Millipore), membranes were blocked in 5% skim milk in tris-buffered
saline with Tween-20 (TBST) and incubated overnight with primary antibodies
against caspase-1 (1:1000 dilution, AG-20B-0042, Adipogen), pIkB (1:1000 dilu-
tion, 2859, Cell Signaling Technologies), IkB (1:1000 dilution, 9242, Cell Signaling
Technologies), pERK (1:1000 dilution, 9101, Cell Signaling Technologies), ERK
(1:1000 dilution, 9102, Cell Signaling Technologies), NLRP3 (1:1000 dilution, AG-
20B-0014, Adipogen), GAPDH (1:10,000 dilution, 5174, Cell Signaling Technolo-
gies), CD14 (1:1000 dilution, 17000-1-AP, Proteintech), GSDMD (1:1000 dilution,
ab209845, Abcam), IL-1β (1:1000 dilution, RDSAF401NA, R&D Systems), NHE-C
(1:200 dilution, NHE-C rabbit antisera), NHE-B (1:1000 dilution, 1E11,
0.8 mg/ml), NHE-A (1:1000 dilution, 1G4, 0.8 mg/ml), or HBL-B (1:1000 dilution,
HBL-B mouse antisera)43,55. PVDF membranes were then incubated with horse-
radish peroxidase-conjugated secondary antibody (1:5000) for 1 h and proteins
were visualized using the Super Signal Femto substrate (34095, ThermoFisher
Scientiﬁc) and the ChemiDoc Touch Imaging System (BioRad). Uncropped full
length immunoblots are provided in the Source Data ﬁle.
Immunoﬂuorescence staining. Immunoﬂuorescence stainings for visualization of
inﬂammasomes were described in our previous publication31. For visualization of
NHE and cell membrane, BMDMs were stimulated with NHE component CWT or
Cmut. or C+ B for 1 h, or C+ B+A for 30 min, washed three times with PBS and
ﬁxed with 4% paraformaldehyde at room temperature for 15 min, followed by
blocking in 1% BSA in PBS for 1 h. Cells were incubated with a rabbit sera anti-
NHE-C (1:200 dilution in 1% BSA)55, a mouse anti-NHE-B, or -A (1:200 dilution
in 1% BSA)55, an mouse anti-Histidine antibody (1:200 dilution in 1% BSA,
ab18184, Abcam), and a rat ﬂuorescein isothiocyanate-conjugated anti-CD11b
antibody (1:200 dilution in 1% BSA, 101205, BioLegend) overnight at 4 °C. PBS
containing 0.05% Tween-20 was used to wash between incubation steps. An anti-
mouse secondary Rhodamine red antibody (115295146, Jackson ImmunoResearch)
or rabbit secondary Rhodamine red antibody (111295144, Jackson ImmunoR-
esearch) were used. The samples were mounted with VECTASHIELD Hardset
Mounting Medium with DAPI (H-1500, Vector Laboratories, Inc.) and analyzed
using a Leica SP5 confocal microscope.
Scanning electron microscopy. BMDMs were washed with PBS and post-ﬁxed
with 2.5% glutaraldehyde in 0.1 M phosphate buffer overnight and further washed
with PBS. Cells were ﬁxed in 1% osmium tetroxide in double distilled water for 1 h
and dehydrated in a series of alcohol. Dehydrated samples were dried using liquid
carbon dioxide using critical point drying. Samples were then sputter-coated with
platinum (3 nm thickness) at 15 mA for 2 min using the EMI TECH K550 Sputter
coater and visualized under a Zeiss UltraPlus Field emission scanning electron
microscope at 5 kV.
Transmission electron microscopy. BMDMs were washed with PBS and post-
ﬁxed with 2.5% glutaraldehyde in 0.1 M phosphate buffer overnight and further
washed with PBS. Cells were ﬁxed in 1% osmium tetroxide in double distilled water
for 1 h and dehydrated in a series of alcohol, and embedded in LR white resin
(C023, ProSciTech). Samples were polymerized in a 60 °C oven overnight. Thin
sections were cut at 80 nm and viewed using a Hitachi HA7100 transmission
electron microscope at 100 kV.
Cryo-transmission electron microscopy. Liposomes left untreated or treated with
recombinant NHEWT or NHEmut. (30 nM) for 1 h were applied on a holey carbon
400 mesh grid and left to adhere for 30 s. Grids were then blotted for 10 s to
remove excess liposomes before plunge frozen using liquid ethane surrounded by a
bath of liquid nitrogen. Samples were visualized under Hitachi 7100 TEM at 100 kv
with a Cryo-TEM holder.
Separation of membrane and cytosolic compartments. BMDMs were stimulated
with the supernatant of ΔHbl B. cereus (50 μl), recombinant NHEWT or NHEmut.
(100 nM), and HBL-BWT, or HBL-Bmut. (5 nM) for 1 h, washed three times with
PBS followed by separation of membrane and cytosolic fractions using the Mem-
PER Plus Membrane Protein Extraction Kit according to the manufacturer’s
instructions (89842, ThermoFisher Scientiﬁc).
Lactate dehydrogenase assay. Levels of lactate dehydrogenase released by cells
were determined using the CytoTox 96 Non-Radioactive Cytotoxicity Assay
according to the manufacturer’s instructions (G1780, Promega).
IncuCyte and cytotoxicity analysis. To track viability, BMDMs or various cell
types were stimulated with 0.5 μM NHE (high) or 100 nM NHE (low), LPS+ATP,
or with 100 nM NHEWT or NHEmut., in presence of the SYTOX Green nuclear
stain that penetrates compromised membranes (1 μM; S7020; Life Technologies).
Cell death was monitored over 3 h using the IncuCyte Zoom imaging system
(Essen Biosciences) or ﬂuorescence was assessed using a Zeiss Axio Observer
Fluorescent/Brightﬁeld microscope.
Real-time PCR analysis. RNA was extracted from BMDMs using TRIzol
(15596018, ThermoFisher Scientiﬁc). The isolated RNA was converted into cDNA
using the High-Capacity cDNA Reverse Transcription Kit (4368813, Thermo-
Fisher). RT-PCR was performed on an ABI StepOnePlus System PCR instrument
with SYBR Green Real Time PCR Master Mixes (4364346, ThermoFisher). Primer
sequences can be found in Supplementary Table 2.
Cytokine analysis. Cytokine concentrations from BMDMs were calculated using a
multiplex ELISA (MCYTOMAG-70K, EMD Millipore) or IL-18 ELISA (BMS618-
3TEN, ThermoFisher) according to the manufacturers’ instructions. Cytokine
levels from THP-1 cells were calculated using a human IL-1β ELISA (BMS224-
2TEN, ThermoFisher) or human IL-18 ELISA (BMS267-2TEN, ThermoFisher)
according to the manufacturer’s instructions.
ICP-OES analysis. The intracellular concentrations of K+ and Na+ ions were
determined by ICP-OES analysis. In brief, BMDMs were stimulated with recom-
binant WT or mutant NHE for 2 h, washed three times with PBS followed by lysis
with concentrated nitric acid (HNO3). The cell lysates were analysed for K+ and
Na+ ions performed through ICP-OES using a PerkinElmer OPTIMA 7300 ICP
Optical Emission Spectrometer (PerkinElmer).
Animal infection. To investigate the role of NHE in inﬂammasome activation
in vivo, WT mice were injected intraperitoneally with 200 μl of supernatant of WT
or ΔHbl B. cereus, which had been treated with either isotype control, anti-HBL-
neutralizing antibodies, anti-NHE-neutralizing antibodies or both anti-HBL-
neutralizing antibodies and anti-NHE-neutralizing antibodies. To investigate
contributions from the NLRP3 inﬂammasome, mice were injected, via an i.p. route,
with 5 × 106 colony-forming units (CFUs) of culture of ΔHbl B. cereus. To inves-
tigate the effects of MCC95036–38, mice were intraperitoneally injected with 50 mg
per kg of MCC950 dissolved in PBS or with an equal amount of the vehicle control
PBS. One hour later, mice were intraperitoneally injected with 5 × 106 CFU of ΔHbl
B. cereus along with a second dose of 50 mg per kg of MCC950 or a second dose of
PBS. For cytokine measurement serum and peritoneal ﬂuid were collected after
1–16 h for analysis by ELISA.
Statistical analysis. The GraphPad Prism 6.0 software was used for data analysis.
Data are shown as mean ± s.e.m. Statistical signiﬁcance was determined by t tests
(two-tailed) for two groups or one-way analysis of variance (with Dunnett’s
multiple-comparisons test) for three or more groups. P < 0.05 was considered
statistically signiﬁcant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are included in this published article
along with its Supplementary Information ﬁles, or are also available from the
corresponding author upon request. The raw data used to make Fig. 1a–d; 2a, b, d; 3a–j;
4a–c; 5a–i; 6c–f; 7a; 8a–e; 9a, c, d; 10a–h and Supplementary Figs. 1b–f; 2a–h; 3a–d, f; 4d;
5a–f; 6a–e; 7a–c; and 10c, d are presented in the Source Data File.
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